Nanobiotix Files September 2025 6-K Report
Ticker: NBTX · Form: 6-K · Filed: Sep 17, 2025 · CIK: 1760854
Sentiment: neutral
Topics: sec-filing, 6-K, compliance
TL;DR
Nanobiotix (NBTX) filed its monthly 6-K report on 9/17/25, confirming it files 20-F annually.
AI Summary
Nanobiotix S.A. filed a Form 6-K on September 17, 2025, to report its activities for the month of September 2025. The company, based in Paris, France, is a pharmaceutical preparations company and is submitting this report under the 1934 Securities Exchange Act. Nanobiotix S.A. is also filing its annual report under cover of Form 20-F.
Why It Matters
This filing provides an update on Nanobiotix S.A.'s ongoing activities and compliance with SEC reporting requirements for foreign private issuers.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer activities and does not contain new financial or operational information that would typically increase risk.
Key Numbers
- 001-39777 — SEC File Number (Identifies the company's filing with the SEC.)
Key Players & Entities
- Nanobiotix S.A. (company) — Registrant
- 001-39777 (company) — SEC File Number
- 20250917 (date) — Filing Date
- September 2025 (date) — Reporting Period
- 60 Rue de Wattignies 75012 Paris, France (address) — Principal Executive Office
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.
What is Nanobiotix S.A.'s primary business?
Nanobiotix S.A. is in the business of pharmaceutical preparations, as indicated by its SIC code 2834.
When was this Form 6-K filed?
This Form 6-K was filed on September 17, 2025.
Does Nanobiotix S.A. file annual reports?
Yes, Nanobiotix S.A. indicates it files annual reports under cover of Form 20-F.
Where is Nanobiotix S.A. headquartered?
Nanobiotix S.A. is headquartered at 60 Rue de Wattignies, 75012 Paris, France.
Filing Stats: 172 words · 1 min read · ~1 pages · Grade level 9.1 · Accepted 2025-09-17 16:43:24
Filing Documents
- f6k_091725.htm (6-K) — 5KB
- exh_991.htm (EX-99.1) — 15KB
- 0001171843-25-005941.txt ( ) — 21KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Nanobiotix S.A. (Registrant) Date: September 17, 2025 /s/ Bart Van Rhijn Bart Van Rhijn Chief Financial Officer